Evidence map›Paper›PMID 32767275›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.

Erick Gustavo Dorlass, Cairo Oliveira Monteiro, Amanda Oliveira Viana, Camila Pereira Soares, Rafael Rahal Guaragna Machado, Luciano Matsumiya Thomazelli, Danielle Bastos Araujo, Fabyano Bruno Leal, Erika Donizette Candido, Bruna Larotonda Telezynski and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. New low-cost biofilters for SARS-CoV-2 usingJournal of cleaner production · 2022
    Article
  17. Article
  18. Review
  19. Recent Chronology of COVID-19 Pandemic.Frontiers in public health · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 6 institutions in 2 countries.

Erick Gustavo DorlassDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Cairo Oliveira MonteiroDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Amanda Oliveira VianaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Camila Pereira SoaresDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Rafael Rahal Guaragna MachadoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Luciano Matsumiya ThomazelliDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Danielle Bastos AraujoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Fabyano Bruno LealDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Erika Donizette CandidoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Bruna Larotonda TelezynskiDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Camila Araujo ValérioDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Vanessa Nascimento ChalupDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Ralyria MelloDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Flavia Jaqueline AlmeidaDepartment of Pediatrics, School of Medical Sciences, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
Andressa Simões AguiarInfection Control Service, São Luiz Gonzaga Hospital of Santa Casa de Misericordia of São Paulo, São Paulo, Brazil.
Anna Carlotta Mott BarrientosInfection Control Service, Municipal Children's Hospital Menino Jesus, São Paulo, Brazil.
Carolina SucupiraInfection Control Service and Epidemiological Hospital Nucleo, Municipal Children's Hospital Candido Fontoura, São Paulo, Brazil.
Milena De PaulisDepartment of Pediatrics, University Hospital, School of Medicine, University of São Paulo, São Paulo, Brazil.
Marco Aurélio Palazzi SáfadiDepartment of Pediatrics, School of Medical Sciences, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
Daniella Gregorio Bonfim Prado SilvaInfection Control Service, São Luiz Gonzaga Hospital of Santa Casa de Misericordia of São Paulo, São Paulo, Brazil.
Janaina Joice Martins SodréInfection Control Service, Municipal Children's Hospital Menino Jesus, São Paulo, Brazil.
Mariana Pereira SoledadeInfection Control Service and Epidemiological Hospital Nucleo, Municipal Children's Hospital Candido Fontoura, São Paulo, Brazil.
Samantha Faria MatosDepartment of Pediatrics, School of Medical Sciences, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
Sabrina Rodrigues FerreiraInfection Control Service, Municipal Children's Hospital Menino Jesus, São Paulo, Brazil.
Célia Miranda Nunez PinezClinical Laboratory Division, Pharmacy and Clinical Laboratory Department, University Hospital, University of São Paulo, São Paulo, Brazil.
Carolina Palamin BuonafineDepartment of Pediatrics, School of Medical Sciences, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
Leticia Nery Ferreira PieroniInfection Control Service, Municipal Children's Hospital Menino Jesus, São Paulo, Brazil.
Fernanda Mello MaltaClinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Rubia Anita Ferraz SantanaClinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Eloisa Corrêa SouzaDepartment of Pediatrics, University Hospital, School of Medicine, University of São Paulo, São Paulo, Brazil.
Ricardo Ambrosio FockDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
João Renato Rebelo PinhoClinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Luís Carlos Souza FerreiraDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Viviane Fongaro BotossoDevelopment and Innovation Center, Laboratory of Virology, Butantan Institute, São Paulo, Brazil.
Edison Luiz DurigonDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Danielle Bruna Leal OliveiraDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. danibruna@gmail.com.ORCID http://orcid.org/0000-0002-0534-0886
Universidade de São Paulo · BRIrmandade da Santa Casa de Misericórdia de São Paulo · BRHospital Israelita Albert Einstein · BRHospital Universitário da Universidade de São Paulo · BRHospital do Servidor Público Municipal · BRInstituto Butantan · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/20045-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/06409-1
6 · The paper itself

Abstract

In March 2020, WHO declared a pandemic state due to SARS-CoV-2 having spread. TaqMan-based real-time RT-qPCR is currently the gold standard for COVID-19 diagnosis. However, it is a high-cost assay, inaccessible for the majority of laboratories around the world, making it difficult to diagnose on a large scale. The objective of this study was to standardize lower cost molecular methods for SARS-CoV-2 identification. E gene primers previously determined for TaqMan assays by Colman et al. (2020) were adapted in SYBR Green assay and RT-PCR conventional. The cross-reactivity test was performed with 17 positive samples for other respiratory viruses, and the sensibility test was performed with 8 dilutions (10 based) of SARS-CoV-2 isolated and 63 SARS-CoV-2-positive samples. The SYBR Green assays and conventional RT-PCR have not shown amplification of the 17 respiratory samples positives for other viruses. The SYBR Green-based assay was able to detect all 8 dilutions of the isolate. The conventional PCR detected until 10

Indexed as

AdolescentAdultAnimalsBenzothiazolesBetacoronavirusChildChlorocebus aethiopsCoronavirus InfectionsCOVID-19Cross ReactionsDiaminesFluorescent DyesHumansMiddle AgedNasopharynxOrganic ChemicalsBenzothiazolesDiaminesFluorescent DyesOrganic ChemicalsQuinolinesRNA, ViralSYBR Green IConventional PCRCOVID-19 pandemicMolecular diagnosesSARS-CoV-2SYBR Green assay

Identifiers

PMID32767275
PMCPMC7411266
OpenAlexW3048290924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.